Last updated
Emerald Clinical Trials: Leadership Change
Emerald Clinical Trials appointed Michael Stibilj as Chief Executive Officer, effective 1 October 2026, to lead the next phase of global growth.
Source: PRN — Retail
- What happened
- Emerald Clinical Trials appointed Michael Stibilj as Chief Executive Officer, effective 1 October 2026, to lead the next phase of global growth.
- Who
- Emerald Clinical Trials · Singapore
- When
- 2026-10-01
- Source
- PRN — Retail
- So what
- A change at the top rarely stays at the top.
The leadership read
A change at the top rarely stays at the top. Emerald Clinical Trials's move reshapes the layer beneath it in the sector as a new leader sets priorities and the team re-forms. Watch the first two or three appointments that follow; they signal direction more reliably than any statement.
Market context: MitchelLake's Talent Market Index sits at 122.7 (Hot), up 17.8 on the prior month; Asia hiring signal is running rising (+8.2pts).
Emerald Clinical Trials: 1 signal in the last 90 days.
MitchelLake in this thematic
More signals across Asia
Leadership Change · Asia
Two Circles →Two Circles appointed media rights veteran Augustine Tan to lead its APAC expansion.
Leadership Change · Asia
Singapore Exchange (SGX) →SGX CEO Loh Boon Chye is stepping down, with succession planning under way; his contract was set to run until July 2027.
Leadership Change · Asia
Singapore Exchange →Singapore Exchange CEO Loh Boon Chye says he is preparing to step down after a decade at the helm as the exchange enters its next growth phase.
Leadership Change · Asia
Korea Federation of Banks →The Korea Federation of Banks, the country's leading banking lobby, is set to appoint a new chairman. Incumbent Cho Yong-byoung leaves office on Nov. 30, and former KB Financial executives and regulators are reported as candidates, with Yoon Jong-kyoo seen as a front-runner.
Leadership Change · Asia
YTL Group →YTL Group has appointed members of the next generation of the Yeoh family to board and alternate director roles across its hospitality, property development and REIT businesses, following 12 next-generation alternate director designations on Sept 24.
Leadership Change · Asia
Bajaj General Insurance →Bajaj General Insurance has named Deepak Reddy as CEO designate; he takes over as Managing Director and CEO from April 1, 2027, while Tapan Singhel continues until March 31, 2027.
Where this lands in our work
- Board Search & Advisory →
Incoming executives reshape governance needs within two quarters.
- Executive Search: Asia →
Our Asia practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗